Immune Hemolytic Anemia
Immune Hemolytic Anemia
Immune Hemolytic Anemia
Susanto Nugroho
Faculty of Medicine
University of Brawijaya
Clinical Competencies
After this session:
Students can describe:
- the pathogenesis of immune hemolytic anemia
- the classification of immune hemolytic anemia
- the principal management of immune hemolytic
anemia
Students can diagnose immune hemolytic anemia
based on clinical features and laboratory findings
Classification
1. Autoimmune hemolytic anemia (AIHA)
a. Warm AIHA
b. Cold AIHA
c. Mixed-type AIHA
2. Alloimmune hemolytic anemia
3. Drug-induced hemolytic anemia
Pathogenesis
Autoimmune Hemolytic Anemia (AIHA)
AIHA are caused by antibody production by the
body against its own red cells: characterized by a
positive DAT or the Coombs test : cold, warm and
mixed-types.
Cold AIHA
The autoantibody attaches to red cells (IgM)
mainly in the peripheral circulation where the
blood temperature is cooled (00C - 40C):
are highly efficient at fixing complement
intravascular & extravascular hemolysis
Pathogenesis.....
Warm AIHA
Warm hemolysis refers to IgG autoantibodies,
which maximally bind RBC at body
temperature (37C).
When warm autoantibodies attach to RBC surface
antigens, these IgG-coated red blood cells are
partially ingested by the macrophages of the
spleen, leaving microspherocytes, the
characteristic cells of AIHA. These
spherocytes, which have decreased
deformability compared with normal red blood
cells, are trapped in the splenic sinusoids and
removed from circulation.
Pathogenesis.....
Mixed AIHA
Some patients with warm AIHA also possess a cold
agglutinin. While the majority of these cold
agglutinin are not clinically significant,
occasionally they have a sufficient thermal
amplitude (greater than 300C) or high titer
(greater than 1:1,000 at0-400C) to indicate
cold agglutinin syndrome (CAS)
Mixed-type AIHA can be either idiopathic or
secondary to lymphoproliferative disorders or
SLE
Pathogenesis.....
Alloimmune Hemolytic Anemia
The most severe alloimmune hemolysis is an
acute transfusion reaction caused by ABOincompatible RBCs, e.g. transfusion of A donor
into O recipient (who has circulating anti-A IgM
antibodies) leads to complement fixation and
a brisk intravascular hemolysis: may occur
fever, chills, dyspnea, hypotension, shock.
Delayed hemolytic transfusion reactions (310 days after a transfusion): caused by low
titer antibodies to minor RBC antigens.
Pathogenesis.....
Drug-Induce Hemolytic Anemia
Three mechanisms of action:
1. drug-absorption (hapten-induced)
2. immune complex
3. autoantibody
These IgG- and IgM-mediated disorders produce a
positive DAT and are clinically and
serologically indistinct from AIHA.
Cold AIHA
Etiologic classification:
1. Idiopathic
2. Secondary:
- Infections: M. pneumonia, infectious
mononucleosis
- Lymphoma
- Paroxysmal cold hemoglobinuria (rare,
sometimes
associated with infections, e.g. syphilis)
Clinical features
Mild jaundice & splenomegaly may be present
May develop acrocyanosis (purplish skin
discoloration) at the tip of the nose, ears,
fingers, and toes caused by the agglutination of
Cold AIHA..
Laboratory findings
Similar to those of warm AIHA, except that
spherocytosis is less marked, red cells
agglutinate in the cold and the DAT reveals
complement (C3d) only on the RBC surface
Management
Treating the underlying cause
Splenectomy does not usually help unless
massive splenomegaly is present, and steroids
are not helpful
Warm AIHA
Etiologic classification
1. Idiopathic
2. Secondary:
- SLE, other autoimmune disease
- CLL, lymphomas
- Drugs, e.g. methyldopa, fludarabine
Clinical features
Occur at any age in either sex and varying
severity
The spleen in often enlarged
Tend to remit and relapse
May occur alone or in association with other
diseases e.g. ITP, SLE or arise as a result of
methyldopa therapy
Warm AIHA..
Laboratory findings
Peripheral blood: typical of an extravascular
hemolytic anemia with spherocytosis prominent
The DAT (+): antibodies are best detected at
370C
Management
Remove the underlying cause (e.g.
methyldopa)
Corticosteroids
Splenectomy
Immunosupression : azathioprine, CPH,
cyclosporine
Folic acid
Blood transfusion
Complications
Thromboembolism
The most common cause of death was
pulmonary
embolism and 27% patients suffered from an
episode of venous thromboembolism
AIHA in patients with SLE: the risk of
thrombosis to be increased more than 4-fold
Lymphoproliferative disorders
Associated immune disorder (e.g., rheumatoid
arthritis, temporal arteritis, Crohns disease,
lupus, thyroiditis, Sjgrens syndrome) and
chronic lymphocytic leukemia
Modul Task
Case:
Mr. P, 35 year-old
History taking: pale 2 week; jaundice; no bleed;
history of fever 2 months ago; acrocyanosis at the
tip of the nose, ears, fingers, and toes.
Physical examination: conjunctiva palpebra
anemic; sclera icteric; spleen enlargement
(Suffner I)
Laboratory results: Hb 6.5 g/dl; WBCs
5640/mm3; platelet 284,000mm3; MCV, MCH and
MCHC normal; peripheral blood smear:
spherocytosis; DAT is positive.
Questions:
1.What is THE MOST PROBABLE DIAGNOSIS of this
patient?
2.Describe in brief CLASSIFICATION &
PATHOGENESIS of this disease!
3.How TO DIAGNOSE each type (warm and cold
type) of this disease based on the clinical
features and laboratory findings?
4.How TO TREAT each type (warm and cold type)
of this disease?
5.How TO TREAT the refractory cases of this
disease?
6.What are COMPLICATIONS of this disease?
Please.discuss this case in your group!!
THANK YOU